DrugInfoSys

Cefotaxime

Drug #140

Cefotaxime is a third generation, semisynthetic cephalosporin antibiotic. ephalosporins are derivatives of 7-aminocephalosporic acid and are closely related to penicillins in structure. Cephalosporins have a six membered sulfur containing ring adjoining a ß lactam ring. Cefotaxime is a broad spectrum antibiotic effective against many organisms that have become resistant to penicillin and aminoglycoside antibiotics. Cefotaxime (Na) is used in the treatment of brain abscess, endocarditis, gonorrhea, maningitis, peritonitis, pneumonia, and septicaemia. Antibiotics require constant drug level in body for therapeutic effect. This is achieved by taking the medication at regular interval of time throughout the day and night as prescribed. Cefotaxime (Na) is important to take the drug for the full time period as prescribed. If you discontinue the therapy, it may result in ineffective treatment.

Primary Characteristics

Cefotaxime is also known as Cefotaxime Na.

It is of Semi Synthetic origin and belongs to Cephem carboxylate.

It belongs to Peptidoglycan synthesis inhibitor pharmacological group on the basis of mechanism of action and also classified in Antibiotic, Cephalosporin-3rd Gen pharmacological group.

Molecular Weight: 478.5 · pKa: 3.75 · Solubility in Water: high · Solubility in Alcohol: insoluble · Non-proprietary name: Cefotaxime.

Molecular structure of Cefotaxime

Pharmacokinetics

Distribution: Cefotaxime has a volume of distribution is 2-37 litre. plasma protein binding is 40%.

Elimination: it is metabolised via Hepatic, plasma half-life is 0.9-1.3 hr, renal excretion is 40%.

Advertisement

Indications

Contraindications

Cefotaxime is contraindicated in conditions like Renal diseases, Hypersensitivity.

Dosage

Cefotaxime's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
4.5 g/dose4.5 g/doseEvery 24hintra abnominal infection
4.5 g4.5 ginfection due to multiresistant organism in 2 to 4 divided doses.
4.5 g4.5 gEvery 24hprophylactic use to redeuce postoperative infections
7 g7 gEvery 4hfor bone and joint infection
4.5 g4.5 gEvery 24hIMGONOCOCCAL INFECTION.
2 – 4 g/doseEvery 12hIV,IMFrequency may be increased to 3 times/day. for uninary tract infection.
4.5 g/dose4.5 g/doseEvery 24hIV,IMfor septicemia and endocarditis
4.5 g/dose4.5 g/doseEvery 24hIV,IMfor septicemia and endocarditis
Paediatric Dosage (20kg)
50 mg50 mgEvery 8hIntra Muscular2 to 4 divided doses. and 200mg dose given in 24hr daily.
50 mg/kg50 mg/kgEvery 8hIntra Venous -
Neonatal Dosage (3kg)
0 – 0
50 – 200IM
50 mg/kg50 mg/kgEvery 8hIntra Muscular -
50 mg/kg50 mg/kgEvery 8hIntra Venous -

Drug Interactions

Unknown3 interactions
5 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Cefotaxime in overdosage may give rise to further complications which include CNS toxicity, Leukopenia, Thrombocytopenia , Eosinophilia .

Cefotaxime produces potentially life-threatening effects which include Pseudomembranous colitis . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Cefotaxime are Encephalopathy.

Cefotaxime is known to cause more or less tolerable side effects which are usually transient. These include Diarrhea, Fever, Hallucination , Nausea, Pain at injection site, Pruritus , Rashes , Thrombophlebitis , Vertigo, Vomiting .

Warnings / Precautions

Cefotaxime should be used with caution in patients with impaired kidney or liver function. Appropriate measure should be taken if secondary infection occurs.

Interference in Pathology

Cefotaxime may interfere in the diagnosis of False +ve results in Redox method for determining the presence of urine glucose. , Affects the bioassay of gentamicin. .

Available Brands

Click on a strength to view available brands.

Multi-Ingredient Combinations

Storage Conditions

Cefotaxime should be stored Dry Powder for Inj. Prefrozen Inj. Thawed .

Drug Classification

  1. 1.6.2.1.3Cephalosporins

Manufacturers